CJC-1295 Buying Guide for Researchers

Sourcing CJC-1295 for research at wholesale comes down to four verifiable things: which form you are actually buying (with DAC or without), a purity figure backed by an HPLC chromatogram you can read yourself, a certificate of analysis tied to the specific lot number on the vial, and pricing terms that hold steady after your first order. Everything else — site design, how fast a rep answers, how confident the marketing copy sounds — tells you nothing about what is in the vial. Real Peptides supplies CJC-1295 (No DAC) at 99%+ HPLC purity with 7-panel batch testing and publicly verifiable COAs, sold for research use only through its Wholesale Partner Program.

This guide is written for the person doing the buying: the lab manager placing repeat orders, the clinic operator building a catalog, the reseller who has to answer purity questions from their own customers. It covers what to check, what to ask, and where the common sourcing traps sit.

Two forms share one name, and that causes most of the confusion

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH), built on a modified 29-amino-acid fragment. It circulates in the research supply chain in two distinct versions, and they are not interchangeable.

The DAC version carries a drug affinity complex — a linker that research literature describes as binding to serum albumin, which extends the compound's half-life in study models. The version without DAC is frequently listed under the name modified GRF (1-29), and studies on GHRH analogs generally describe a much shorter activity window for it. Researchers select between them based on the pharmacokinetic profile a given study design calls for, not because one is a better-grade material than the other.

The practical sourcing problem is naming. A listing that says only "CJC-1295" is ambiguous, and some suppliers are careless about which one they ship. Before any order goes out, confirm the form in writing and confirm that the certificate of analysis identifies the sequence and molecular weight — not just the trade name. If a supplier cannot tell you which molecule is in the vial without checking with someone, that is your answer about their batch control.

A purity percentage answers one question out of seven

HPLC purity is the number everyone quotes, and it is worth quoting: it expresses what share of the peptide-related material in the vial is the target peptide rather than truncated sequences, deletion products, or synthesis byproducts. A 99%+ figure is a meaningful quality bar.

It is also narrow. HPLC purity says nothing about identity confirmation, net peptide content versus counterion and residual moisture, endotoxin load, bioburden, heavy metals, or residual solvents from synthesis. A vial can be 99% pure peptide and still carry problems that a chromatogram was never designed to detect. That is why multi-panel batch testing matters more than any single headline number, and why Real Peptides runs a 7-panel test on each batch rather than publishing a purity figure alone.

When you compare suppliers, compare panels, not percentages. Ask which assays are run, on what schedule, and whether they are performed per batch or on an occasional sampling basis. "We test our products" is not a specification. "Every lot is tested across these named panels and the results are posted" is.

Reading a certificate of analysis before you commit to a purchase order

A COA is only useful if it is traceable to the material you are holding. Most of the failures in this category are not forged documents — they are real documents disconnected from the shipment. Use the checks below on any supplier, including this one.

That last row deserves emphasis, because charging for a certificate of analysis — or releasing it only to buyers who have already paid — remains a live practice in this industry. A COA is quality documentation for material you are considering, not a premium add-on. Real Peptides publishes COAs so a buyer can verify lab results independently before an order is placed.

How wholesale pricing and minimums actually work

Wholesale peptide pricing is almost always tiered: unit cost declines as committed volume rises, with breakpoints set per compound. What varies wildly between suppliers is the structure underneath the tiers, and that structure determines whether your costs are predictable.

Ask these questions before you model anything:

Is the minimum per SKU or per order? A blended order minimum lets you stock several compounds at once. A per-SKU minimum forces depth in each line and changes your inventory risk entirely.

Do tiers reset? Some programs evaluate volume per order; others aggregate across a rolling period. This materially affects a buyer with steady, modest reorders.

Is the published price the price? Opaque "request a quote" pricing is not automatically dishonest, but it makes comparison impossible and gives the supplier room to price each buyer differently. If you cannot see terms before you commit time to an application, you cannot compare.

What happens on a failed or short batch? Replacement policy, hold-and-retest procedure, and who absorbs freight are all worth settling in advance rather than during a problem.

Be skeptical of anyone — including a content page like this one — who hands you specific margin percentages, markup multiples, or profitability timelines. Those numbers depend on your category mix, order volume, freight, and market, and any published range is a guess dressed as data. Margins vary widely with volume and category. Build your model from real quoted terms, not from an article.

Due diligence that extends past the vial

Fulfillment is where a supplier relationship either holds or breaks. Confirm where orders ship from, what the stated lead time is, and whether that lead time survives a reorder in a busy month. Real Peptides fulfills from within the US with a stated 5–7 day window, which is a figure you can hold the program to rather than a promise of "fast shipping."

Look at the labeling, too. Research-use-only material should be labeled as such, clearly and without ambiguity, and a supplier's own marketing should match that framing. A vendor whose product pages describe outcomes for people is telling you something about its compliance posture — and by extension, about the risk it may transfer to you as a downstream buyer.

On the legal and licensing side, treat every question as one to resolve with your own counsel rather than with a supplier. Whether your business entity may purchase, hold, or resell research compounds, what registrations or licenses may apply in your jurisdiction, how your state board views the activity, and how products must be labeled and recorded are all questions with jurisdiction-specific answers that change. The useful move is to arrive at your attorney's office with a written list: what we intend to buy, in what volume, who we intend to sell to, and what documentation we will keep. This article is informational and is not legal advice; nothing here should be read as a conclusion about what your jurisdiction permits.

Why a credible supplier will not send you a protocol

Buyers ask about reconstitution and dosing constantly, and the answer from any compliant research supplier is the same: Real Peptides does not provide dosing, titration, or preparation guidance, because these are research-use-only compounds and are not FDA-approved drugs for human use. That is not evasiveness. A supplier willing to hand out protocols is a supplier whose compliance controls you should assume are weak everywhere else, including in the lab.

What is legitimately discussable is specification. Vials are supplied at a stated milligram quantity of lyophilized peptide, and concentration in any research context is simply a function of milligrams per milliliter — that framework is the ceiling of what a supplier should educate on. Study design, handling, and anything downstream of the vial belong to the qualified researcher and their institutional oversight, not to the vendor.

What Real Peptides does differently

The Wholesale Partner Program is built around documentation a buyer can check without a phone call. Every batch is tested to a 99%+ HPLC purity standard and run through a 7-panel analysis, and the resulting COAs are published for independent verification — you can look up the lab results yourself rather than requesting them, paying for them, or taking a claim on faith. Orders are fulfilled from within the US on a 5–7 day window.

Access runs through a 3-step wholesale application: submit your business details, complete verification, and receive tiered pricing on approval. The catalog is research-use-only throughout, and the compound selection spans growth factor and tissue signaling research alongside metabolic, recovery, and longevity categories — relevant if you intend to stock adjacent compounds rather than a single line.

Where a qualified buyer goes next

If you are sourcing CJC-1295 (No DAC) for research and you want a supplier whose purity, panel testing, and lot documentation can be checked before you place an order, the Wholesale Partner Program application at Real Peptides is the entry point. Bring your business details and your intended volume; approved partners receive tiered pricing and ongoing access to published batch documentation.

To review specifications directly, see CJC-1295 No DAC 10mg, compare it against related research compounds such as Ipamorelin 10mg and Tesamorelin 10mg, or browse the broader Growth Factor & Tissue Signaling Research collection.